is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
CPhI & P-MEC India is closely monitoring developments concerning the Coronavirus COVID-19. The health and safety of both our customers and colleagues is always our top priority. As such, we are following all safety advice and precautions as recommended by local Departments of Health, as well as the World Health Organization (WHO).
2020 edition saw a rise in overall attendees, with harmonization and innovation driving increased industry dynamism.
The Booming Indian Pharmaceutical Market, a future powerhouse for R&D and manufacturers of pharmaceuticals with 17,000+ pharma companies and 70-80% of branded generics in the retail market.
What does 2019 have in store for Pharma? We asked industry Thought Leaders to name one disruptive trend or technology that will have a significant impact on the market in the year ahead.
Savita V Jayaram looks at the reasons for slow growth in India’s agrichemical manufacturing industry, the impediments to change and the barriers to reducing dependency on Chinese imports.
CPhI & P-MEC India opens as report ranks India the world’s fastest improving pharma market and first for ‘growth potential’ for 2019.
Biopharmaceutical drugs are normally manufactured at large facilities dedicated to a single product, using processes that are difficult to reconfigure. To help make more of these drugs available, MIT researchers have developed a new way to rapidly manufacture biopharmaceuticals on demand.
By Vicky Qing Xia & Ronald A. Rader.
Posted on www.pharmoutsourcing.com
Recent growth in the biopharmaceutical industry in both China, and India suggest a future positive outlook for contract manufacturing in both regions.
The 2017 CPhI Indian Pharma insight report is designed to evaluate the overall growth prospects of domestic Indian Pharma companies and foreign pharmaceutical companies working within the India pharmaceutical market.
The new venue will see the exhibition now hosted in a single venue, bringing it closer to the Indian regulatory and legislative capital. New Delhi is also the country’s main international transport hub and will encourage an increased international attendance. In total, more than 50,000 people from 122 countries are expected, along with nearly 1500 exhibitors.